These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17494866)

  • 1. Depletion of the nucleolar protein nucleostemin causes G1 cell cycle arrest via the p53 pathway.
    Ma H; Pederson T
    Mol Biol Cell; 2007 Jul; 18(7):2630-5. PubMed ID: 17494866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2.
    Dai MS; Sun XX; Lu H
    Mol Cell Biol; 2008 Jul; 28(13):4365-76. PubMed ID: 18426907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleostemin: a multiplex regulator of cell-cycle progression.
    Ma H; Pederson T
    Trends Cell Biol; 2008 Dec; 18(12):575-9. PubMed ID: 18951797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleostemin knocking-down causes cell cycle arrest and apoptosis in human T-cell acute lymphoblastic leukemia MOLT-4 cells via p53 and p21Waf1/Cip1 up-regulation.
    Rahmati M; Moosavi MA; Zarghami N
    Hematology; 2014 Dec; 19(8):455-62. PubMed ID: 24628257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2-ARF complex regulates p53 sumoylation.
    Chen L; Chen J
    Oncogene; 2003 Aug; 22(34):5348-57. PubMed ID: 12917636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleolar GTP-binding Protein-1 (NGP-1) Promotes G1 to S Phase Transition by Activating Cyclin-dependent Kinase Inhibitor p21 Cip1/Waf1.
    Datta D; Anbarasu K; Rajabather S; Priya RS; Desai P; Mahalingam S
    J Biol Chem; 2015 Aug; 290(35):21536-52. PubMed ID: 26203195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleolar Arf sequesters Mdm2 and activates p53.
    Weber JD; Taylor LJ; Roussel MF; Sherr CJ; Bar-Sagi D
    Nat Cell Biol; 1999 May; 1(1):20-6. PubMed ID: 10559859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53.
    Zhang Y; Xiong Y
    Mol Cell; 1999 May; 3(5):579-91. PubMed ID: 10360174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleostemin: Another nucleolar "Twister" of the p53-MDM2 loop.
    Lo D; Lu H
    Cell Cycle; 2010 Aug; 9(16):3227-32. PubMed ID: 20703089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts.
    García JF; Villuendas R; Sánchez-Beato M; Sánchez-Aguilera A; Sánchez L; Prieto I; Piris MA
    Am J Pathol; 2002 Feb; 160(2):569-78. PubMed ID: 11839577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PML regulates p53 stability by sequestering Mdm2 to the nucleolus.
    Bernardi R; Scaglioni PP; Bergmann S; Horn HF; Vousden KH; Pandolfi PP
    Nat Cell Biol; 2004 Jul; 6(7):665-72. PubMed ID: 15195100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells.
    Tsai RY; McKay RD
    Genes Dev; 2002 Dec; 16(23):2991-3003. PubMed ID: 12464630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GNL3L depletion destabilizes MDM2 and induces p53-dependent G2/M arrest.
    Meng L; Hsu JK; Tsai RY
    Oncogene; 2011 Apr; 30(14):1716-26. PubMed ID: 21132010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleostemin stabilizes ARF by inhibiting the ubiquitin ligase ULF.
    Lo D; Zhang Y; Dai MS; Sun XX; Zeng SX; Lu H
    Oncogene; 2015 Mar; 34(13):1688-97. PubMed ID: 24769896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the MDM2-p53 pathway by the nucleolar protein CSIG in response to nucleolar stress.
    Xie N; Ma L; Zhu F; Zhao W; Tian F; Yuan F; Fu J; Huang D; Lv C; Tong T
    Sci Rep; 2016 Nov; 6():36171. PubMed ID: 27811966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleoplasmic mobilization of nucleostemin stabilizes MDM2 and promotes G2-M progression and cell survival.
    Meng L; Lin T; Tsai RY
    J Cell Sci; 2008 Dec; 121(Pt 24):4037-46. PubMed ID: 19033382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel role of nucleostemin in the maintenance of nucleolar architecture and integrity of small nucleolar ribonucleoproteins and the telomerase complex.
    Romanova L; Kellner S; Katoku-Kikyo N; Kikyo N
    J Biol Chem; 2009 Sep; 284(39):26685-94. PubMed ID: 19648109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro study of nucleostemin as a potential therapeutic target in human breast carcinoma SKBR-3 cells.
    Guo Y; Liao YP; Zhang D; Xu LS; Li N; Guan WJ; Liu CQ
    Asian Pac J Cancer Prev; 2014; 15(5):2291-5. PubMed ID: 24716972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of nucleostemin causes G1 cell cycle arrest via a p53-independent pathway in prostate cancer PC-3 cells.
    Liu R; Zhang Z; Xu Y
    Urol Int; 2010; 85(2):221-7. PubMed ID: 20664182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways.
    Zhao L; Samuels T; Winckler S; Korgaonkar C; Tompkins V; Horne MC; Quelle DE
    Mol Cancer Res; 2003 Jan; 1(3):195-206. PubMed ID: 12556559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.